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Abstract
The protozoan parasite Leishmania major causes cutaneous lesions to develop at the site of infection, which are
resolved with a strong Th1 immune response in resistant hosts, such as C57BL/6 mice. In contrast, the lesions
ulcerate in susceptible hosts which display a Th2 response, such as BALB/c mice. The migration of cells in the
immune response to L. major is regulated by chemokines and their receptors. The chemokine receptor CCR7 is
expressed on activated DCs and naïve T cells, allowing them to migrate to the correct micro-anatomical positions
within secondary lymphoid organs. While there have been many studies on the function of CCR7 during homeostasis
or using model antigens, there are very few studies on the role of CCR7 during infection. In this study, we show that
B6.CCR7-/- mice were unable to resolve the lesion and developed a chronic disease. The composition of the local
infiltrate at the lesion was significantly skewed toward neutrophils while the proportion of CCR2+ monocytes was
reduced. Furthermore, a greater percentage of CCR2+ monocytes expressed CCR7 in the footpad than in the lymph
node or spleen of B6.WT mice. We also found an increased percentage of regulatory T cells in the draining lymph
node of B6.CCR7-/- mice throughout infection. Additionally, the cytokine milieu of the lymph node showed a Th2 bias,
rather than the resistant Th1 phenotype. This data shows that CCR7 is required for a protective immune response to
intracellular L. major infection.
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Introduction
The efficient movement of cells during ontogenesis,
homeostatic recirculation and inflammatory recruitment is
governed by a family of G protein-coupled seven-
transmembrane spanning receptors that specifically bind to
small chemotactic cytokines termed chemokines [1,2]. In the
mammalian immune system, the navigation of cell subsets is
facilitated by distinct expression patterns of chemokine
receptors on the cell surface and the presentation of their
ligands in the form of fixed gradients in peripheral and lymphoid
tissues [3]. Ultimately, this targeted movement is central for the
induction of tolerance and the generation of a protective
immune response [4].
One of the most important events in the generation of a
cellular immune response is the encounter of antigen-specific
naïve T cells with antigen presenting cells. Antigen
presentation occurs in the T cell zone of secondary lymphoid
organs, such as lymph nodes and spleen, under the guidance
of an array of chemokine receptors and their ligands [5] and
results in the differentiation of T cells into a range of effector
phenotypes [6]. However, one receptor, CC-chemokine
receptor 7 (CCR7) which is expressed on naïve and memory T
cells, and in addition, on monocytes and antigen-presenting
cells, has been described to play a dominant role in this
process [7]. Despite the seemingly central function of this
chemokine receptor, protective immune responses have been
reported in a variety of CCR7-deficient models of viral [8,9] and
bacterial infection [10], and it has been discussed that the
magnitude of the role of CCR7 is inversely proportional to the
amount of antigen that initiates the response [10].
While cutaneous leishmaniasis has been studied in a model
with transgenically decreased CCR7 expression,
toxoplasmosis is the only parasitic model investigated to date
in the CCR7-/- mouse model, and this model shows a high
degree of susceptibility [11,12]. Therefore, we decided to test
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the role of CCR7 in a gene-deficient model during experimental
cutaneous leishmaniasis. Under normal circumstances, the
infection is confined to the skin and local draining lymph node,
and is resolved quickly in immunocompetent hosts such as
C57BL/6 mice, but can spread to the visceral organs and
progress to a fatal outcome in immunocompromised hosts [13].
The analysis of L. major infected B6.CCR7-/- mice showed an
influence of this receptor on the recruitment of monocytes, the
regulation of the adaptive immune response and the local
cytokine milieu in the draining lymph node. Taken together,
these alterations contribute to a failure to resolve the infection




Genetically targeted C57BL/6 mice deficient for CCR7
(B6.CCR7-/-, B6.129P2(C)-Ccr7tm1Rfor/J, [14]) and control
C57BL/6J (B6.WT) mice were obtained from Jackson
Laboratory (Bar Harbor, USA). The mice were screened
according to the previously published protocol [14]. All animals
were kept under specific pathogen free conditions at the animal
research facilities of the Comparative Genomics Centre, James
Cook University, Townsville, Australia and the Menzies
Research Institute Tasmania, Hobart, Australia. Mice of both
sexes were infected at 8-12 weeks of age.
Ethics Statement
The experiments followed protocols approved by the animal
ethics committees of James Cook University, Townsville under
ethics numbers A1170 and A1492, and the University of
Tasmania, Hobart under ethics number A11656.
Leishmania
The pathogenic parasite substrains L. major BNI
(MHOM/IL/81/FE/BNI) and L. major Friedlin expressing eGFP
(MHOM/IL/80/Friedlin-eGFP) were maintained and expanded
in supplemented Schneider’s media (Life Technologies,
Mulgrave, Australia) essentially as published [15]. Immediately
prior to infection, parasites were passaged onto rabbit blood
agar plates in supplemented RPMI media for 6-8 days as
described [15]. To maintain infectivity, the parasites were
passaged through BALB/c mice. Mice were infected
subcutaneously with 3x106 L. major promastigotes in the hind
footpad. Footpad lesions were measured using a metric caliper
to determine disease progression as described [16].
Flow cytometry
Tissues were harvested from infected footpads, draining
popliteal lymph nodes and spleens. Leukocytes were isolated
by mechanical disruption of the tissue and were restimulated
with phorbol 12-myristate 13-acetate (PMA; 20 ng/mL),
ionomycin (1 μM) and protein transport inhibitor (monensin; BD
GolgiStop) for four to six hours. Multi-colour flow cytometry was
performed following a three-step protocol. First, cells were
blocked for unspecific Fc binding with rat anti-mouse CD16/32
(clone 93; eBioscience, San Diego, USA). Secondly, cells were
stained for surface markers: rat anti-mouse Ly6C (FITC; clone
AL-21; BD Pharmingen), rat anti-mouse Ly6G (PE; clone 1A8;
BD Pharmingen), rat anti-mouse CD11b (PerCP-Cy5.5; clone
M1/70; BD Pharmingen), Armenian hamster anti-mouse CD11c
(APC; clone HL3; BD Pharmingen), rat anti-mouse CD4
(PerCP-Cy5.5; clone RM4-5; BD Pharmingen), rat anti-mouse
CD8a (Pacific Blue; clone 53-6.7; BD Pharmingen) and rat anti-
mouse CD25 (APC-Cy7 or PE; clone PC61; BD Pharmingen).
The rat anti-mouse CCR2 antibody (unlabelled, clone MC-21)
was provided by M. Mack, Regensburg, Germany [17]. The
cells were then fixed according to the manufacturer’s
instructions with FoxP3 Fix/Perm buffer (BioLegend, San
Diego, USA) and permeabilized with either Perm buffer
(BioLegend) or saponin (Sigma-Aldrich, Sydney, Australia) in
PBS. In the third step, the cells were stained intracellularly with
rat anti-mouse IL-17 (PE; clone TC11-18H10; BD Pharmingen),
rat anti-mouse/rat FoxP3 (APC; clone FJK-16s; eBioscience),
rat anti-mouse IL-10 (PE; clone JES5-16E3; BD Pharmingen),
rat anti-mouse IFN-γ (Alexa Fluor 488; clone XMG1.2; BD
Pharmingen), rat anti-mouse IL-12 (p40/p70) (APC; clone
C15.6; BD Pharmingen) and rat anti-mouse IL-4 (PE; clone
11B11; BD Pharmingen). A polyclonal rabbit serum was used
to detect mouse iNOS (pAb, BD Biosciences). Donkey anti-rat
IgG (Dylight 649; Jackson Immunoresearch, West Grove, USA)
and goat anti-rabbit IgG (Pacific Blue; Molecular Probes,
Mulgrave, Australia) were used as secondary antibodies. Cells
were acquired on a Beckman Coulter CyAn ADP flow
cytometer using Summit version 4.3 and samples were
analysed using FlowJo software (Tree Star, Inc.). Non-
leukocytic populations in the footpad were excluded by forward
and side scatter analysis.
Cytometric bead array
Cytometric bead arrays (CBA) were performed on serum
collected from the peripheral blood of infected mice. CBA flex
sets for IFN-γ, IL-12p70, IL-1β, TNF, IL-4 and IL-10 (BD
Biosciences) were used to determine cytokine levels and the
manufacturer’s instructions were essentially followed. Samples
were acquired on a BD FACSCanto II using FACSDiva 6.1
software and analysed with FCAP Array version 1.0 software.
Limiting dilutions
Limiting dilution experiments were performed to determine
the parasite burden in infected footpads and draining popliteal
lymph nodes. Single cell suspensions were prepared in
supplemented Schneider’s media and serial dilutions (5-fold)
were pipetted across a 96-well plate with eight replicates for
each organ in an end-point titration. The plates were incubated
for 10-14 days at 27°C before the number of Leishmania-
positive wells was determined under a light microscope. To
calculate the parasite burden a generalised Pearson chi-square
test was performed (L-Calc version 1.1). Alternatively, extreme
limiting dilution analysis (ELDA) was used [18].
Confocal Microscopy
Spleens and draining lymph nodes were isolated from
B6.WT and B6.CCR7-/- mice, rapidly frozen in Tissue Tek
CCR7 Deficiency in Cutaneous Leishmaniasis
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optimal cutting temperature (OCT) media (ProSciTech,
Townsville, Australia) and stored at -80°C. Sections were cut
using a cryotome (Leica, North Ryde, Australia), air-dried and
fixed in acetone at -20°C. Prior to staining, sections were re-
hydrated in PBS+1% BSA for 15 minutes and then
permeabilised in TBS+0.1% Tween-20 for 15 minutes if
intracellular markers were examined.
Sections were stained using rat anti-mouse B220 (clone
RA3-6B2; BD Pharmingen), rat anti-mouse CD11b (biotin;
clone M1/70; BD Pharmingen), rat anti-mouse Ly6C (FITC;
clone AL-21; BD Pharmingen), rat anti-mouse Ly6G (PE; clone
1A8; BD Pharmingen), mouse anti-mouse iNOS (FITC; clone 6/
iNOS/NOS type II; BD Transduction Laboratories) and rabbit
anti-L. major serum (Cy5; [19]). Secondary staining was
performed using streptavidin conjugated to Alexa Fluor 546 or
FITC (Life Technologies) and goat anti-rat IgG (Alexa Fluor
633; Life Technologies) before the sections were mounted with
polyvinyl alcohol mounting media with DABCO (Sigma-Aldrich)
to prevent fading and allowed to dry overnight. Images were
acquired using a Zeiss LSM 510 confocal microscope.
Blocking of IL-10R and IL-4 in vivo
Mice were injected intraperitoneally every second day,
starting the day prior to L. major infection, with PBS, anti-IL-4
(clone 11B11, obtained from hybridoma supernatant) or anti-
IL-10R (clone 1B1.3a, obtained from hybridoma supernatant).
The draining popliteal lymph node was analysed at day 14 post
infection by flow cytometry.
Statistical analysis
A two-tailed Mann-Whitney test or an unpaired t test was
performed using GraphPad Prism 5 for Mac OS X, version 5.0a
(GraphPad Software, San Diego, USA) to determine p values.
A p value below 0.05 was considered statistically significant.
Results
Cutaneous leishmaniasis in B6.CCR7-/- mice
Subcutaneous infection of the footpad with L. major
metacyclic promastigotes causes a lesion that is typically
resolved with little scarring within 8-10 weeks in B6.WT mice
[16]. In the infection of B6.WT and B6.CCR7-/- mice presented,
we saw a two-phasic footpad swelling (peaks at day 21 and
day 105) in the clinically healthy control group (Figure 1A). In
contrast, B6.CCR7-/- mice were unable to heal the lesion and
developed a chronic infection resulting in a permanent swelling
of the footpad (Figure 1A). Unlike L. major infection of
susceptible BALB/c mice, the lesions of B6.CCR7-/- mice did
not ulcerate.
In the human immune system, CCR7 has been shown to be
a marker for central memory cells [20], which generally home
to secondary lymphoid organs. Therefore, we explored the
possibility that this chemokine receptor facilitates an adaptive
memory response to L. major. When B6.CCR7-/- mice were
reinfected in the contralateral footpad after 174 days, they first
appeared to clear the infection similar to B6.WT mice,
according to lesion size, indicating no major impact of CCR7
deficiency on memory formation (Figure 1A). Six weeks after
reinfection, the response of the control B6.WT mice subsided
and the lesion resolved, whereas the lesion size in B6.CCR7-/-
mice increased again and remained enlarged for an extended
period of time.
The parasite burden in the infected footpad and draining
lymph node was quantified during the first four weeks of
infection by performing limiting dilutions. At day 14, before the
peak of infection, B6.CCR7-/- mice initially controlled parasite
replication in the footpad (Figure 1B), but by day 28 after
infection, B6.CCR7-/- mice had an increase in the number of
parasites in the footpad as compared to B6.WT mice (161820 ±
75472 [mean ± SEM] and 19346 ± 7621, respectively, p=0.03).
In contrast, we could not detect a significant difference in
parasite numbers in the draining lymph nodes of the two
genotypes (Figure 1C). We concluded that while B6.CCR7-/-
mice may be able to control parasite dissemination at an early
stage of infection, there is a breakdown of the control, which
allows parasites to replicate and cause a chronic disease in
these mice.
In the mice reinfected for the analysis of the memory
response (Figure 1A), the amount of parasites in the
contralateral footpad was quantified. Although there were no
detectable parasites in B6.WT mice, a substantial number
could be found in the footpad tissue in B6.CCR7-/- mice (149.1
± 38.6 parasites/gram of tissue, n=3 mice), further
demonstrating a role for CCR7 in control of the replication of
parasites within the footpad tissue.
Increased neutrophilic infiltrate at the expense of
CCR2+ monocytes
The monocytic and neutrophilic populations in the infected
lesion, draining lymph node and spleen were analysed by flow
cytometry at days 14, 28 and 42 after infection. These
timepoints were chosen to analyse any early changes to the
immune response (day 14) and any differences at the peak of
infection (day 28). The disease progression between the two
genotypes differentiates at day 42 after infection, so this
timepoint was used to determine any factors that contribute to
the chronic infection. Monocytes were identified using CD11b
and further classified into various populations according to their
Ly6C expression. These subpopulations were additionally
analysed for their Ly6G, CCR2 and iNOS expression, and
representative plots are shown in Figure S1. At day 14 after
infection, three monocytic populations were defined in the
lesion, draining lymph node and spleen (Figure 2A). The Ly6Clo
population (population 1) represented tissue resident
monocytes as suggested by their low CCR2 and iNOS
expression in the footpad and lymph node (Figure 2C&D).
Increased Ly6G expression in B6.CCR7-/- splenic monocytes
indicated a portion of neutrophilic cells (Figure 2E). Population
2 (Ly6Cint) had increased Ly6G expression and could be
identified as neutrophilic in the lesion and spleen (Figure 2E).
The proinflammatory capability of population 2 could be
decreased in B6.CCR7-/- mice compared to B6.WT mice as
shown by their lower CCR2 and iNOS expression (Figure
2C&D). Finally, the Ly6Chi population (population 3) showed
high CCR2 expression and was consequently identified as
CCR7 Deficiency in Cutaneous Leishmaniasis
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Figure 1.  Disease progression in B6.CCR7-/- mice after infection with L. major.  (A) Mice were infected subcutaneously with L.
major and the footpad lesion was measured weekly with a metric caliper. The lesion size was compared to the mean of the
uninfected footpads from each experimental group (100%). Mice were infected subcutaneously in the contralateral footpad at day
174 post infection to measure the memory response. In accordance with animal ethics guidelines to minimise the usage of mice,
this experiment was conducted at the same time as previously published data, and as a result, the lesion size of B6.WT mice has
been published [61]. The parasite burdens in the footpad (B) and draining lymph node (C) were determined by limiting dilutions at
days 14 and 28 post infection for B6.WT (closed circles) and B6.CCR7-/- (open circles) mice. One representative analysis of two
experiments; Experimental group size: n=5 mice/genotype; *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g001
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inflammatory monocytes (Figure 2C). Furthermore, the
proportion of Ly6Chi cells was increased in the footpad of
B6.CCR7-/- mice (Figure 2B).
At day 14 after infection, the percentage of CD11c+ cells
expressing CCR7 in B6.WT mice was 74.3% (±2.5 [SEM]) in
the footpad, 25.1% (±2.1) in the lymph node and 43.3% (±2.2)
in the spleen (Figure 3A). In the footpad, 78.7% (±1.5) of
CCR2+ monocytes also expressed CCR7, while 45.5% (±2.3)
and 21.3% (±1.7) of CCR2+ cells were CCR7+ in the lymph
node and spleen, respectively (Figure 3B&C). According to the
populations described in Figure 2A, a larger proportion of
population 1 (Ly6Clo) in the footpad expressed CCR7. There
was no difference in expression between the three populations
in the lymph node (Figure 3D), while in the spleen, population 3
(Ly6Chi) had a greater percentage of cells expressing CCR7.
The expression of CCR7 was also analysed on Ly6G+ cells
[21], which were confirmed by flow cytometry to be neutrophilic
due to their high side scatter profile. In the footpad, 30.4%
(±3.3) of Ly6G+ cells were CCR7+, while in the lymph node
13.3% (±3.1) and in the spleen 7.2% (±0.25) were also CCR7+
(Figure 3E).
By day 28 after infection, the monocytic populations had
differentiated further and formed three populations in the
footpad, two in the lymph node and four in the spleen (Figure
4A). In the footpad, population 1 appeared similar in both
genotypes in terms of CCR2, iNOS and Ly6G expression
(Figure 4C-E). Population 2 was neutrophilic as demonstrated
by its increased Ly6G expression (Figure 4E) and the
percentage of the previously CCR2+ inflammatory monocytes
(population 3) was significantly reduced in B6.CCR7-/- mice,
and showed only a fraction of previous CCR2 expression
(Figure 4B&C). In the lymph node of B6.CCR7-/- mice, the
percentage of non-inflammatory monocytes in population 1
(Ly6Clo) had increased, while the previous inflammatory
population 2 (Ly6Chi) displayed a more neutrophilic phenotype
as demonstrated by decreased iNOS and increased Ly6G
expression (Figure 4D&E). In the spleen of B6.CCR7-/- mice,
population 1 showed decreased iNOS expression compared to
the B6.WT subset (Figure 4D). Population 2 expressed Ly6G,
and resembled neutrophils (Figure 4E) while populations 3 and
4 had increased CCR2 expression, which was indicative of
inflammatory monocytes (Figure 4C).
At day 42 after infection, the monocytic populations
appeared similar to the subpopulations detected on day 28
(Figure 5A). The lymph nodes of B6.CCR7-/- mice had
increased percentages of both monocytic populations (Figure
5B). There was also increased iNOS expression by monocytes
in the spleen of B6.CCR7-/- mice (Figure 5D). Overall, at this
timepoint, the inflammatory infiltrate in all tissues of B6.CCR7-/-
mice was composed of Ly6G+ neutrophils (Figure 5E), rather
than CCR2+ inflammatory monocytes (Figure 5C).
Monocyte and neutrophil migration is dysregulated
within the spleen and lymph node of B6.CCR7-/- mice
Based on the flow cytometry data, we analysed the structure
of the spleens at day 14 after infection. Tissue was sectioned
and stained for the in situ location of monocytes, neutrophils
and L. major. In B6.CCR7-/- spleens, most CD11b+ cells were
also Ly6C+ (Figure 6A) indicating the dominant presence of
inflammatory monocytes (Ly6Chi) or neutrophils (Ly6Clo). In
contrast, the majority of CD11b+ cells in B6.WT mice did not
express Ly6C+ (Figure 6A). Histologically, in B6.WT mice,
these CD11b+Ly6C+ cells were excluded from the B220+ B cell
follicle, while in B6.CCR7-/- mice, CD11b+Ly6C+ cells appeared
to be located in all compartments of the spleen, including the B
cell follicle (Figure 6A). While L. major parasites are visible in
clusters in B6.WT mice [19] they were distributed throughout
the spleen of B6.CCR7-/- mice (Figure 6B). In B6.WT mice, both
myeloid (CD11b+) and non-myeloid (CD11b-) cells expressed
iNOS, whereas in B6.CCR7-/- mice, the parasites and iNOS
expression was co-localised within CD11b+ cells. The parasite
burden of neutrophils was specifically analysed in the draining
lymph node 24 hours after infection (Figure 6C). Neutrophils
harboured L. major parasites in both B6.WT and B6.CCR7-/-
mice. While parasites could only be found in neutrophils in
B6.WT mice after 24 hours post infection, other cells had taken
up parasites in B6.CCR7-/- lymph nodes (Figure 6C). Taken
together, the monocytes are not confined to their usual
compartments in B6.CCR7-/- mice and may interact with other
cells that would otherwise not be in proximity with each other.
Increased IL-12, but not IFN-γ, and increased IL-4 after
infection in B6.CCR7-/- lymph nodes
Intracellular flow cytometry was employed to analyse
cytokine expression on a cellular basis. Cells were gated for
the cytokine and CD4 or CD8 expression (Figure 7A). The
proportion of CD4+IFN-γ+ T cells was increased significantly in
B6.CCR7-/- mice as compared to B6.WT mice at day 14 after
infection (Figure 7B). By day 28 post infection both genotypes
displayed an increased number of CD4+IFN-γ+ T cells, which
was more pronounced in B6.WT mice (Figure 7B). However,
IFN-γ was predominately produced by CD8+ T cells in equal
proportions in both B6.WT and B6.CCR7-/- mice. The level of
IL-12 peaked at day 28 in B6.CCR7-/- mice, while they
remained relatively stable in B6.WT mice (Figure 7C).
Furthermore, B6.CCR7-/- mice had a greater percentage of
cells producing IL-12 at days 14 and 28 post infection than
B6.WT mice (Figure 7C) and most of this production was by
cells other than T cells.
The Th2 cytokine, IL-4, which is present in susceptible mice
[22], was also analysed. Initially, at day 14 post infection, there
is a large percentage of cells expressing IL-4, which then
decreased at days 28 and 42 post infection (Figure 8).
Furthermore, at days 28 and 42 post infection, B6.CCR7-/- mice
have a higher percentage of cells expressing IL-4, which was
also seen in the CD4+ compartment but not by CD8+ T cells.
Other cells, such as basophils and mast cells, contribute to the
excess IL-4 production, not provided by T cells [23,24].
Increased immunosuppression in lymph nodes lacking
CCR7
The expression of IL-10 and the transcription factor Foxp3
was analysed to determine the immunosuppressive capability
of B6.CCR7-/- mice. The percentage of IL-10 producing cells
decreased throughout infection in both genotypes (Figure 9A).
At day 28 post infection there was an increase in IL-10-
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Figure 2.  Monocytic populations in the footpad, lymph node and spleen at day 14 post infection.  (A) CD11b+ monocytes
from the footpad, lymph node and spleen were classified into different populations according to their Ly6C expression using flow
cytometry. (B) The percentage of total cells recovered from each tissue in B6.WT (closed circles) and B6.CCR7-/- (open circles) mice
was determined for each population. The percentage of cells from each population expressing CCR2 (C), iNOS (D) and Ly6G (E)
was determined by flow cytometry. One representative analysis of three experiments; Experimental group size: n=5 mice/genotype;
*p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g002
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Figure 3.  CCR7 expression in B6.WT mice at day 14 after infection with L. major.  (A) The percentage of CD11c+ cells
expressing CCR7 was determined by flow cytometry in the footpad, draining lymph node (LN) and spleen. (B) The expression of
CCR7 on CD11b+CCR2+ monocytes was determined in each tissue of B6.WT mice. (C) A representative histogram of CCR7
expression on CD11b+CCR2+ monocytes in each tissue is shown. (D) Monocytic populations were defined according to their
expression of Ly6C as shown in Figure 2A, and the percentage of cells in each population expressing CCR7 is shown. (E) The
percentage of Ly6G+ neutrophils in each tissue expressing CCR7 was analysed by flow cytometry. Experimental group size: n=5
mice.
doi: 10.1371/journal.pone.0079098.g003
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Figure 4.  Monocytic populations in B6.WT and B6.CCR7-/- mice at day 28 after infection with L. major.  (A) Flow cytometry
was used to determine monocytic populations in the footpad, lymph node and spleen according to their CD11b and Ly6C
expression. (B) The percentage of the total cell number recovered from each tissue is shown for B6.WT (closed circles) and
B6.CCR7-/- (open circles) mice for each monocytic population. The percentage of cells in each population expressing CCR2 (C),
iNOS (D) and Ly6G (E) was determined. One representative analysis of three experiments; Experimental group size: n=5 mice/
genotype; *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g004
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Figure 5.  Characterisation of monocytic populations in B6.WT and B6.CCR7-/- mice at day 42 post infection.  (A) Populations
of monocytes in each tissue were defined by flow cytometry according to their CD11b and Ly6C expression. (B) The percentage of
these populations in each tissue is shown in B6.WT (closed circles) and B6.CCR7-/- (open circles) mice. The expression of CCR2
(C), iNOS (D) and Ly6G (E) was determined by flow cytometry and displayed as a percentage of each population. One
representative analysis of three experiments; Experimental group size: n=5 mice/genotype; *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g005
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Figure 6.  Fluorescent immunohistology of B6.WT and B6.CCR7-/- spleens at day 14 post infection and lymph nodes 24
hours after infection.  (A) Frozen spleens from day 14 post infection were sectioned and stained with antibodies against B220
(green), CD11b (blue) and Ly6C (red) to show localisation of monocytes in the spleen. (B) Expression of iNOS (green), CD11b
(blue) and L. major (red) was shown in the spleen. (C) The draining popliteal lymph node was taken at 24 hours after infection with
L. major expressing eGFP (red) and analysed for Ly6G (green) expression. B=B cell follicle; Objective magnification: A&B 20x; C
63x.
doi: 10.1371/journal.pone.0079098.g006
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producing cells in B6.CCR7-/- mice, which was also seen in
CD8+ cells. Some of the IL-10 production is by cells other than
T cells, and could be the result of monocytic or dendritic cell
expression [25].
Regulatory T cells (Tregs) were recognised by the
expression of both CD25 and Foxp3 (Figure 9B). Throughout
the infection there was an increased proportion of CD4+ cells
expressing Foxp3 in B6.CCR7-/- mice (Figure 9C). Additionally,
there was some Foxp3 expression by CD8+ cells, which
increased significantly at day 42 post infection in B6.CCR7-/-
mice (Figure 9C). These CD8+Foxp3+ T cells have not yet been
described functionally in parasitic diseases, but could represent
cells with suppressive ability [26]. While TGF-β and IL-2
promote the differentiation of Tregs, TGF-β and IL-6 induce
Th17 differentiation and inhibit the development of Tregs [27].
Due to the reciprocal developmental pathway, Th17 cells
(CD4+IL-17+) were also analysed, and an increased percentage
was seen only at day 28 after infection in B6.CCR7-/- mice (data
not shown).
Since there were increased Tregs present in B6.CCR7-/-
mice, the mechanism behind this accumulation was analysed.
Due to the observation of an increase in the Th2 and
Figure 7.  Cellular expression of Th1 cytokines in the lymph node of mice infected with L. major.  (A) Intracellular expression
of IL-12 and IFN-γ was determined by flow cytometry. (B) The expression of IFN-γ in B6.WT (closed circles) and B6.CCR7-/- (open
circles) mice is shown as a percentage of all lymph node cells as well as a the percentage of CD4+ or CD8+ cells expressing IFN-γ.
(C) The expression of IL-12 was shown in a similar manner to IFN-γ. One representative analysis of three experiments;
Experimental group size: n=5 mice/genotype for each timepoint; *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g007
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immunosuppressive cytokines IL-4 and IL-10, we explored the
possibility that these cytokines played a role in promoting Treg
differentiation in B6.CCR7-/- mice. We therefore injected mice
for two weeks with a blocking anti-IL-10R antibody or a
neutralising anti-IL-4 antibody in an attempt to decrease the
percentage of Tregs. While the percentage of Tregs in the
lymph node decreased in B6.WT mice injected with an anti-IL-4
antibody compared to control B6.WT mice injected with PBS,
the percentage of Tregs remained unchanged in B6.CCR7-/-
mice, irrespective of antibody treatment (Figure 9D). This data
show that the increase in Tregs in the lymph nodes of
B6.CCR7-/- mice is independent of IL-10 or IL-4 signalling.
Overall, there is an early increase in the macrophage-
activating Th1 cytokines IFN-γ and IL-12, followed by an
increase in Th2 and immunosuppressive cytokines from the
peak of disease into the chronic stage of infection in B6.CCR7-/-
mice. The cytokine production by cellular sources correlated
with the systemic production of proinflammatory and
immunosuppressive cytokines in the serum (Figure S2).
Furthermore, there is an increased percentage of Tregs
throughout infection. The skewing of the immune response to a
detrimental Th2 and immunosuppressive response at the late
stages may contribute to the inability to clear the parasites from
B6.CCR7-/- mice and cause a chronic infection.
Discussion
The chemokine receptor CCR7 has been studied
comprehensively in homeostasis and inflammation [7]. This
extensive body of work demonstrates, for example, a clearly
defined role of CCR7 in the homing of naïve T cells to lymph
nodes [14]. However, an analysis of the function of this
receptor in complex infection models shows that there is
tolerance, allowing cell migration in the absence of CCR7
under inflammatory conditions [8,10]. We sought to determine
the effects of the absence of CCR7 on the resolution of
leishmaniasis, as well as the composition and function of the
inflammatory infiltrate. After subcutaneous infection with L.
major, B6.CCR7-/- mice were unable to resolve the lesion and
developed a chronic infection. Furthermore, we found a
significantly increased number of neutrophils present in the
infected footpad, draining lymph node and spleen, as well as
delayed migration of CCR2+ inflammatory monocytes. A further
analysis of CCR2+ monocytes showed significant CCR7
expression. Finally, we observed that the balance of helper T
cell cytokines in the lymph node was skewed towards a Th2
phenotype, and we detected an increased percentage of Tregs
throughout infection.
In an infection with viral or bacterial agents, which require a
host immune response dominated by cytotoxic CD8+ T cells for
clearance of the pathogen, CCR7-/- mice display a delayed, but
ultimately protective response [8,10]. However, infection of
B6.CCR7-/- mice with the parasite Toxoplasma gondii, which
requires a CD4+ Th1 response, results in death during the
acute phase of the disease due to uncontrolled parasite
replication and dissemination [11]. In our experiments, infection
of B6.CCR7-/- mice with L. major, which is also eliminated by a
protective Th1 response [28,29], does not result in death, but
the mice are still unable to clear the parasite, and suffer from a
chronic infection (Figure 1A). Together, these studies during
infection demonstrate that the functions of CCR7 are largely
redundant for cytotoxic T cell responses but indicate that they
are critical for Th1 responses against intracellular parasites.
This could be due to a requirement for CCR7-dependent
migration of cells that present antigen via MHC class II to CD4+
T cells, while MHC class I restricted presentation to CD8+ T
cells relies only in part on the migration of cells to lymphoid
organs [14,30].
Inflammatory monocytes expressing the chemokine receptor
CCR2 are critical for the clearance of intracellular parasites by
antigen presentation and by utilising a range of effector
mechanisms, such as iNOS [19,31–35]. While it is well
established that the presence of CCR2+ monocytes is essential
for the elimination of both T. gondii and L. major from the site of
infection [19,31], the influence of other chemokine receptors,
such as CCR7, on the migration of these cells has not been
explored in more detail, despite indirect evidence of delayed
migration in the absence of CCR7. Similar to our L. major
Figure 8.  Expression of the Th2 cytokine, IL-4, in the lymph node of infected mice.  The percentage of all lymph node
leukocytes as well as the percentage of CD4+ or CD8+ cells expressing IL-4 was determined by intracellular flow cytometry in B6.WT
(closed circles) and B6.CCR7-/- (open circles) mice. One representative analysis of three experiments; Experimental group size: n=5
mice/genotype for each timepoint; *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g008
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Figure 9.  Immunosuppression in the lymph nodes of B6.WT and B6.CCR7-/- during infection with L. major.  (A) Expression
of IL-10 in the total lymph node, as well as in the CD4+ and CD8+ compartments was determined by flow cytometry in B6.WT
(closed circles) and B6.CCR7-/- (open circles) mice. (B) CD4+ or CD8+ Tregs were determined by their dual expression of CD25 and
Foxp3. (C) The total percentage of Foxp3+ cells as well as the percentage of CD4+ and CD8+ Tregs in the total population was
determined by intracellular flow cytometry. (D) Mice were injected intraperitoneally with PBS, anti-IL-10R or anti-IL-4, and the
draining lymph node analysed for the percentage of CD4+ Tregs at day 14 post infection. A&C, One representative analysis of three
experiments; Experimental group size: n=5 mice/genotype for each timepoint; D, One experimental analysis; Experimental group
size: n=3 mice/genotype for each treatment. *p<0.05; **p<0.01.
doi: 10.1371/journal.pone.0079098.g009
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 model, CCR7-/- mice infected with T. gondii show a reduced
migration of CCR2+ inflammatory monocytes to the site of
infection [11]. This supports evidence that CCR7 is required for
the migration of monocytes into inflamed tissue, while the role
of CCR2 seems to be limited to migration from the bone
marrow to the circulation [36,37]. For the first time in an
infection model, we have shown that the majority of CCR2+
monocytes in the footpads of B6.WT mice also express CCR7
(Figure 3B). However, it is unknown if these monocytes have
recently been recruited to the site of infection, or if they have
upregulated CCR7 in preparation for migration to the draining
lymph node.
The CCR7-dependent migration of cells depends on the
tissue-specific gradients of its ligands [3]. In mice, CCR7 has
two ligands, CCL19 and CCL21, with CCL21 displaying two
isoforms differing in one amino acid, CCL21-Ser and CCL21-
Leu [1,38]. The expression of the chemokines CCL19 and
CCL21 is usually associated with lymphoid organs,
nevertheless, CCL21-Leu is also constitutively expressed in
non-lymphoid organs, and CCL21-Ser can be upregulated
within lung tissue upon inflammation [38,39]. Furthermore, in a
visceral leishmaniasis model, CCL21 expression correlates
with parasite burden in the dermis of infected dogs [40].
Combined with the ability of CCL21 to be expressed in non-
lymphoid tissues and the delayed migration of inflammatory
monocytes to the footpad in the absence of CCR7, it could be
speculated that CCR7, rather than CCR2, is required for the
inflammatory recruitment of monocytes to the site of infection
[11].
The immune response to Leishmania, like any other
infection, is shaped by the presence of Tregs [41]. Specifically,
in the model of cutaneous leishmaniasis, Tregs prevent
complete eradication of the parasite from the host through
IL-10 mediated mechanisms [42]. Chemokine receptors,
including CCR7, are known to be important for the migration
and function of Tregs [43,44]. In wild type mice, CCR7 is
present on a subset of Tregs that do not express αE integrin
(CD103), a molecule involved in the detainment of Tregs at the
site of infection [45–47]. Consequently, these Tregs home to
lymph nodes, whereas in the absence of CCR7, there is
retention of Tregs at inflamed sites [45,48]. More specifically,
while CCR7-/- Tregs are suppressive in vitro, these cells are
less efficient in vivo after ovalbumin sensitisation, due to
impaired migration to lymphoid tissues and incorrect
localisation within the target lymphoid organs [45,46,49]. This is
of particular relevance for L. major infection, since CD4+CD25+
Tregs prevent a sterile cure, and therefore, there is potential for
reactivation of leishmaniasis [41,42,50]. In our model, L. major
infection causes an increase in the percentage of Tregs in the
draining lymph node (Figure 9C), as well as the infected
footpad (data not shown) in the absence of CCR7, potentially
contributing to the increased parasite burden and chronically
enlarged lesion [42].
The model of cutaneous leishmaniasis has been beneficial in
the elucidation of the Th1/Th2 paradigm [51]. A Th1 response
is characterised by IFN-γ and IL-12 expression, while a Th2
response is characterised by IL-4 production, and the T cell
responses are associated with resistance or susceptibility,
respectively [22]. The genetic background of C57BL/6 mice is
able to mount a protective response, but in infected B6.CCR7-/-
mice, the T cell response was skewed towards a susceptible
Th2 phenotype. The skewing of the immune system towards a
Th2 phenotype in B6.CCR7-/- mice has also been shown using
an ovalbumin sensitisation model [52]. However, despite an
increase in IL-4 expression, these CCR7-deficient mice do not
develop a progressive disease, but instead develop a chronic
infection. This supports the notion that the mechanisms
responsible for resistance only rely in part on cytokine
production. Recent studies have shown that the wound healing
response can also play a role in resistance or susceptibility to
the parasite and this response is characterised by collagen
deposition [53,54]. In the skin, several different cell types
contribute to wound healing, such as fibrocytes and
mesenchymal stem cells. In an interesting coincidence, CCR7
and its ligands have also been shown to be centrally involved
in wound healing [55–58]. In pulmonary fibrosis, a model of
exacerbated wound healing, the absence of CCR7 alleviates
the disease, and in a skin injury model, fibrocytes are able to
migrate to wound sites and enhance healing in a CCR7-
dependent manner [59,60]. Furthermore, mesenchymal stem
cells are able to migrate to skin wounds in response to CCR7
ligands and support wound healing [57]. Since we showed that
B6.CCR7-/- mice have an enlarged lesion for an extended
period of time, it could be speculated that the wound healing
process is inefficient in these mice. Our data indicate that the
CCR7-deficient infection model may be beneficial to address
other mechanisms of susceptibility and resistance to L. major
infection, such as the wound healing response.
In summary, the chemokine receptor CCR7 plays a role in
the migration of inflammatory monocytes and Tregs. Disruption
of the normal function and migration of these cells in the
absence of CCR7 during cutaneous leishmaniasis causes a
chronic infection. Our data further demonstrates that the role of
CCR7 is extremely complex in infection models, and more
studies are required to further elucidate the mechanisms of
action between CCR7 and its ligands.
Supporting Information
Figure S1.  Representative flow cytometric analysis of
monocytes. Representative staining of splenic samples from
day 28 post infection are shown for CCR2 expression (A),
iNOS expression (B) and Ly6G expression (C) within each
monocytic population described in Figure 4.
(TIFF)
Figure S2.  Cytokine levels in the serum of B6.WT and
B6.CCR7-/- mice throughout infection with L. major.
Cytometric bead arrays were used to determine the levels of
(A) IFN-γ, (B) IL-12p70, (C) IL-1β, (D) TNF, (E) IL-4 and (F)
IL-10 in the serum of infected mice at days 14, 28 and 42 post
infection. Experimental group size: n=5 mice/genotype for each
timepoint; ND=not detectable.
(TIFF)
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